LSFG-SKIN, Laser Speckle Flowgraphy
LSFG-SKIN, Laser Speckle Flowgraphy
What it found
The trial ended early for another reason (see below).
Reason given: This study was stopped 3/2/18 as the company who supported the device went out of business and requested the device be returned. Only 1 control subject was tested, no analyzable data.
What was tested
Treatment tested
- laser speckle flowgraphy
Safety
| Group | Participants at risk | Serious adverse events | Deaths |
|---|---|---|---|
| Clinic Subjects | 1 | 0 (0.0%) | 0 |
As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.
What it measured
Main measures
Imaging Blood Flow
One visit
Who could take part
MS (type not specified) · 18 to 90
Show the full criteria
Inclusion criteria
Controls ●Healthy normal control subjects ages 18-90 Cardiology Subjects * Ages 18-90 * History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral vascular disease Dermatology Subjects * Ages 18-90 * History of inflammatory and cancerous lesions Endocrine Subjects * Ages 18-90 * History of diabetes, thyroid disease Neurology Subjects * Ages 18-90 * History of dementia, headaches, Parkinson's, light sensitivity, stroke, TIA, multiple sclerosis Psychiatry Subjects * Ages 18-90 * History of bipolar, schizophrenia, anxiety, depression Surgery Subjects * Ages 18-90 * History of skin wounds(trauma, chemotherapy, radiation), thermal burns, or plastic and reconstructive surgical procedures. Ophthalmology Subjects * Ages 18-90 * History of ocular disorders caused by hypo perfusion or inflammatory disorders
Exclusion criteria
Controls * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Cardiology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma 3. Dermatology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Endocrine Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Neurology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Psychiatry Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Surgery Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma Ophthalmology Subjects * Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. * Angle closure glaucoma
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.
Loading reviews and guidelines…
History
Started
May 2017
Main results due
Mar 2019
Finished
Mar 2019
Results posted
May 2023